NO895087L - Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater. - Google Patents
Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater.Info
- Publication number
- NO895087L NO895087L NO89895087A NO895087A NO895087L NO 895087 L NO895087 L NO 895087L NO 89895087 A NO89895087 A NO 89895087A NO 895087 A NO895087 A NO 895087A NO 895087 L NO895087 L NO 895087L
- Authority
- NO
- Norway
- Prior art keywords
- eter
- derivatives
- procedure
- preparation
- therapeutic active
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
- C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
- C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D327/00—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms
- C07D327/02—Heterocyclic compounds containing rings having oxygen and sulfur atoms as the only ring hetero atoms one oxygen atom and one sulfur atom
- C07D327/04—Five-membered rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds That Contain Two Or More Ring Oxygen Atoms (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP88403311 | 1988-12-23 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO895087D0 NO895087D0 (no) | 1989-12-18 |
| NO895087L true NO895087L (no) | 1990-06-25 |
Family
ID=8200452
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO89895087A NO895087L (no) | 1988-12-23 | 1989-12-18 | Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US5098932A (de) |
| EP (1) | EP0375457B1 (de) |
| JP (1) | JPH03135976A (de) |
| AU (1) | AU622965B2 (de) |
| CA (1) | CA2006095A1 (de) |
| DE (1) | DE68913940T2 (de) |
| DK (1) | DK665089A (de) |
| ES (1) | ES2063149T3 (de) |
| FI (1) | FI896015A7 (de) |
| GB (1) | GB8927287D0 (de) |
| HU (1) | HUT52494A (de) |
| IE (1) | IE63211B1 (de) |
| IL (1) | IL92580A (de) |
| NO (1) | NO895087L (de) |
| NZ (1) | NZ231666A (de) |
| PT (1) | PT92701A (de) |
| ZA (1) | ZA899688B (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE902113A1 (en) * | 1989-07-18 | 1991-06-19 | Ici Plc | Diaryl ether cyclic ethers |
| US5254581A (en) * | 1990-06-21 | 1993-10-19 | Imperial Chemical Industries Plc | Pyran derivatives and their use as inhibitors of 5-lipoxygenase |
| IE914005A1 (en) * | 1990-12-14 | 1992-06-17 | Zeneca Ltd | Novel intermediates |
| CA2058254A1 (en) * | 1991-01-15 | 1992-07-16 | John Francis Kingston | Benzodioxole derivatives |
| IL100483A0 (en) * | 1991-01-17 | 1992-09-06 | Ici Plc | Sulphonamide derivatives |
| US5258399A (en) * | 1991-01-17 | 1993-11-02 | Imperial Chemical Industries Plc | Sulphonamide derivatives |
| EP0505122A1 (de) * | 1991-03-21 | 1992-09-23 | Zeneca Limited | Alpha, Alpha-Dialkylbenzylderivate |
| EP0532239B1 (de) * | 1991-09-10 | 1995-12-13 | Zeneca Limited | Benzolsulfonamidderivate als 5-Lipoxygenasehemmer |
| GB9300894D0 (en) * | 1992-02-07 | 1993-03-10 | Zeneca Ltd | Oxime derivatives |
| EP0555067A1 (de) * | 1992-02-07 | 1993-08-11 | Zeneca Limited | Hydroxylaminderivate als 5-Lipoxygenasehemmer |
| CA2094465A1 (en) * | 1992-04-23 | 1993-10-24 | Pierre Andre Raymond Bruneau | Cycloalkane derivatives |
| CA2095005A1 (en) * | 1992-05-12 | 1993-11-13 | Philip Neil Edwards | Hydroxylamine derivatives |
| CA2095006A1 (en) * | 1992-05-12 | 1993-11-13 | Philip Neil Edwards | Oxime derivatives |
| US5231197A (en) * | 1992-06-01 | 1993-07-27 | General Electric Company | Method for producing ethylenically unsaturated graftable orthoesters |
| DE4228201A1 (de) * | 1992-08-25 | 1994-03-03 | Schering Ag | Neue Leukotrien-B¶4¶-Antagonisten, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| AU4444393A (en) * | 1992-09-01 | 1994-03-10 | Zeneca Limited | Pyrrolidine derivatives |
| WO1994005638A1 (en) * | 1992-09-02 | 1994-03-17 | Abbott Laboratories | Trans 1,4-diether cyclohexane inhibitors of 5-lipoxygenase |
| US5446062A (en) * | 1993-11-12 | 1995-08-29 | Abbott Laboratories | ((4-alkoxypyran-4-yl) substituted) ether, arylalkyl-, arylalkenyl-, and arylalkynyl)urea inhibitors of 5-lipoxygenase |
| US5407959A (en) * | 1993-11-12 | 1995-04-18 | Abbott Laboratories | (Trans-1,4-dialkoxycyclohexyl) substituted arylalkylaryl-arylalkenylaryl-, and arylalkynylarylurea inhibitors of 5-lipoxygenase |
| US6512121B2 (en) | 1998-09-14 | 2003-01-28 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| US5643933A (en) * | 1995-06-02 | 1997-07-01 | G. D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| US6515014B2 (en) | 1995-06-02 | 2003-02-04 | G. D. Searle & Co. | Thiophene substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| CA2223154A1 (en) | 1995-06-02 | 1996-12-05 | G.D. Searle & Co. | Heterocyclo substituted hydroxamic acid derivatives as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| ATE301457T1 (de) * | 1995-06-12 | 2005-08-15 | Searle & Co | Mittel, enthaltend einen cyclooxygenase-2 inhibitor und einen 5-lipoxygenase inhibitor |
| WO1997029776A1 (en) | 1996-02-13 | 1997-08-21 | G.D. Searle & Co. | Combinations having immunosuppressive effects, containing cyclooxygenase-2-inhibitors and 5-lipoxygenase inhibitors |
| AU1952597A (en) | 1996-02-13 | 1997-09-02 | G.D. Searle & Co. | Combinations, having immunosuppressive effects, containing cyclooxygenase-2 inhibitor and a leukotriene a4 hydrolase inhibitor |
| US6677364B2 (en) * | 1998-04-20 | 2004-01-13 | G.D. Searle & Co. | Substituted sulfonylphenylheterocycles as cyclooxygenase-2 and 5-lipoxygenase inhibitors |
| CN1468055A (zh) * | 2000-10-03 | 2004-01-14 | �����ɷ� | 苯基丙炔基羟吡啶除草剂 |
| ES2732293T3 (es) | 2007-02-22 | 2019-11-21 | Childrens Hospital & Res Center At Oakland | Formulaciones de ácidos grasos y métodos para el uso de las mismas |
| EP3423429B1 (de) | 2016-03-03 | 2023-07-12 | Universite De Moncton | Modulatoren der lypoxygenase- und cyclooxygenaseenzymaktivität |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3743737A (en) * | 1970-05-21 | 1973-07-03 | Smith Kline French Lab | 3-sulfonamido-4-hydroxyphenyl-2-piperindinylcarbinol compositions |
| US3661917A (en) * | 1970-05-21 | 1972-05-09 | Smith Kline French Lab | 3-sulfonamido-4-hydroxyphenyl-2-piperidylcarbinols |
| CA960676A (en) * | 1970-05-21 | 1975-01-07 | Smith Kline And French Canada Ltd. | 3-sulfonamido-4-hydroxyphenyl-2-piperidinylcarbinols |
| IE56702B1 (en) * | 1982-12-01 | 1991-11-06 | Usv Pharma Corp | Antiinflammatory antiallergic compounds |
| NO174506B (no) * | 1984-10-30 | 1994-02-07 | Usv Pharma Corp | Analogifremgangsmaate ved fremstilling av terapeutisk aktive forbindelser |
| US4625034A (en) * | 1985-02-04 | 1986-11-25 | Usv Pharmaceutical Corp. | 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives |
| US4839369A (en) * | 1985-04-16 | 1989-06-13 | Rorer Pharmaceutical Corporation | Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments |
| US4876346A (en) * | 1985-05-02 | 1989-10-24 | American Home Products Corporation | Quinoline compounds |
| EP0271287A3 (de) * | 1986-12-11 | 1990-06-13 | Merck Frosst Canada Inc. | Chinolindicarbonsäuren und ihre Amide |
| US4920133A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| US4920132A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| US4920130A (en) * | 1987-11-02 | 1990-04-24 | Rorer Pharamceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| US4920131A (en) * | 1987-11-03 | 1990-04-24 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene D4 |
| US4918081A (en) * | 1988-06-20 | 1990-04-17 | Rorer Pharmaceutical Corp. | Quinoline derivatives and use thereof as antagonists of leukotriene d4 |
| EP0349062A1 (de) * | 1988-06-27 | 1990-01-03 | Merck Frosst Canada Inc. | Chinolinetheralkansäuren |
-
1989
- 1989-12-01 GB GB898927287A patent/GB8927287D0/en active Pending
- 1989-12-05 IE IE388189A patent/IE63211B1/en not_active IP Right Cessation
- 1989-12-06 IL IL9258089A patent/IL92580A/xx not_active IP Right Cessation
- 1989-12-07 NZ NZ231666A patent/NZ231666A/en unknown
- 1989-12-15 FI FI896015A patent/FI896015A7/fi not_active Application Discontinuation
- 1989-12-15 HU HU896627A patent/HUT52494A/hu unknown
- 1989-12-18 NO NO89895087A patent/NO895087L/no unknown
- 1989-12-18 ZA ZA899688A patent/ZA899688B/xx unknown
- 1989-12-20 CA CA002006095A patent/CA2006095A1/en not_active Abandoned
- 1989-12-21 AU AU47147/89A patent/AU622965B2/en not_active Ceased
- 1989-12-22 US US07/454,911 patent/US5098932A/en not_active Expired - Fee Related
- 1989-12-22 PT PT92701A patent/PT92701A/pt not_active Application Discontinuation
- 1989-12-22 DE DE68913940T patent/DE68913940T2/de not_active Expired - Fee Related
- 1989-12-22 ES ES89313521T patent/ES2063149T3/es not_active Expired - Lifetime
- 1989-12-22 DK DK665089A patent/DK665089A/da not_active Application Discontinuation
- 1989-12-22 EP EP89313521A patent/EP0375457B1/de not_active Expired - Lifetime
- 1989-12-25 JP JP1333011A patent/JPH03135976A/ja active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| NO895087D0 (no) | 1989-12-18 |
| EP0375457A2 (de) | 1990-06-27 |
| AU622965B2 (en) | 1992-04-30 |
| DE68913940D1 (de) | 1994-04-21 |
| IL92580A (en) | 1994-04-12 |
| EP0375457B1 (de) | 1994-03-16 |
| IE63211B1 (en) | 1995-04-05 |
| HUT52494A (en) | 1990-07-28 |
| EP0375457A3 (de) | 1991-01-09 |
| DK665089A (da) | 1990-06-24 |
| AU4714789A (en) | 1990-06-28 |
| IE893881L (en) | 1990-06-23 |
| PT92701A (pt) | 1990-06-29 |
| US5098932A (en) | 1992-03-24 |
| ZA899688B (en) | 1990-08-29 |
| GB8927287D0 (en) | 1990-01-31 |
| ES2063149T3 (es) | 1995-01-01 |
| NZ231666A (en) | 1992-01-29 |
| CA2006095A1 (en) | 1990-06-23 |
| FI896015A0 (fi) | 1989-12-15 |
| IL92580A0 (en) | 1990-08-31 |
| FI896015A7 (fi) | 1990-06-24 |
| JPH03135976A (ja) | 1991-06-10 |
| DK665089D0 (da) | 1989-12-22 |
| DE68913940T2 (de) | 1994-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO895087D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive cykliske eter-derivater. | |
| NO894630L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinuklidin-derivater. | |
| NO871266L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO883974D0 (no) | Fremgangsmaate for fremstilling av terapeutiske aktive tetrahydro-hydroksypyranon-derivater. | |
| NO904694L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazolderivater. | |
| NO901684D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 3-substituerte-2-oksindol-derivater. | |
| NO870526L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater. | |
| NO874032L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater. | |
| NO874153D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazo-benzoksazinon-derivater. | |
| NO883122D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive arylamid-derivater. | |
| NO875488D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater. | |
| NO893909L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive imidazol-derivater. | |
| NO862372D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinolonderivater. | |
| NO891723L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater. | |
| NO167739C (no) | Anologifremgangsmaate for fremstilling av terapeutisk aktive ginkolid-derivater. | |
| NO891114D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive arakidonsyre-derivater. | |
| NO167802C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive benzotiazepinderivater. | |
| NO864101D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilinderivater. | |
| NO900972D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive naftalen-derivater. | |
| NO890607L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyridin-derivater. | |
| NO871907D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater. | |
| NO874780D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrrolo-benzimidazol-derivater. | |
| NO913187D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tricykliske derivater. | |
| NO900942D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive azacyklooktadien-derivater. | |
| NO890724D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive tetraazaacenaftylen-derivater. |